Noteworthy here is that we used the same REH ALL mouse model in our previous publication (28) where we showed that the C6 hinge in a CD19 CAR is as efficacious as a commonly used CD8-derived hinge to control B-cell leukemia in vivo by CAR T cells. The gene discussed is CD8A; the disease is acute lymphoblastic leukemia.